Literature DB >> 10961179

A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals.

F ter Borg1, F J ten Kate, H T Cuypers, A Leentvaar-Kuijpers, J Oosting, P M Wertheim-van Dillen, P Honkoop, M C Rasch, R A de Man, J van Hattum, R A Chamuleau, G N Tytgat, E A Jones.   

Abstract

AIMS: To use laboratory data and liver biopsies, prospectively obtained from hepatitis B surface antigen (HBsAg) and anti hepatitis B e antigen (anti-HBe) positive patients, for the assessment of: (1) the relation between biopsy length/number of portal tracts and sampling error; (2) the relation between the severity of piecemeal necrosis and the new grading terminology (minimal, mild, moderate, and severe chronic hepatitis); and (3) liver pathology, which has not been studied in patients with this specific serological profile.
METHODS: The study group (n = 174) included 104 patients with normal aminotransferase concentrations and no cases with clinically apparent cirrhosis. The specimen length and number of portal tracts were measured at light microscopy examination. Sampling error analysis was related to the discrepancies between aminotransferase concentrations versus histological grade. Detailed histological scorings were undertaken by the reference pathologist and compared with laboratory and hepatitis B virus (HBV) DNA precore sequence data.
RESULTS: Sampling error seemed to be a constant feature, even for biopsies > or = 20 mm, but increased dramatically in biopsies < 5 mm long and/or containing less than four portal tracts. Between 25% and 30% of biopsies, graded as "mild" or "moderate" activity showed features of moderate and severe piecemeal necrosis, respectively. Ten per cent of the patients with normal aminotransferase values had stage III-IV hepatic fibrosis, and 20% had piecemeal necrosis. Only cytoplasmic, not nuclear, core antigen expression was a strong predictor of high hepatitis B viraemia. There was no association between precore stop codon mutations, grade/stage of liver disease, and hepatitis B core antigen (HBcAg) expression.
CONCLUSIONS: The specimen available for light microscopical examination should be > 5 mm long and should contain more than four portal tracts. In addition, the new grading terminology might give the clinician an inappropriately mild impression of the severity of piecemeal necrosis. Furthermore, even in the presence of normal aminotransferase concentrations, considerable liver pathology can be found in 10-20% of HBsAg and anti-HBe positive individuals; such pathology is not associated with the occurrence of precore stop codon mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961179      PMCID: PMC1731225          DOI: 10.1136/jcp.53.7.541

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  44 in total

1.  Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen.

Authors:  R P Perrillo; E M Brunt
Journal:  Ann Intern Med       Date:  1991-07-15       Impact factor: 25.391

2.  Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis.

Authors:  M Omata; T Ehata; O Yokosuka; K Hosoda; M Ohto
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

3.  Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.

Authors:  M R Brunetto; M M Giarin; F Oliveri; E Chiaberge; M Baldi; A Alfarano; A Serra; G Saracco; G Verme; H Will
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

4.  Significance of hepatitis B core antigen in the liver in patients with chronic hepatitis B and its relation to hepatitis B virus DNA.

Authors:  J Y Yoo; H Y Kim; C K Park; S K Khang; J W Jeong; W K Chung; A M Dibisceglie; J H Hoofnagle
Journal:  J Gastroenterol Hepatol       Date:  1990 May-Jun       Impact factor: 4.029

5.  HBV-DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy.

Authors:  M Rapicetta; V di Nardo; C Rozera; G Marinucci; D Francisci; B Sarrecchia; C Ricci; F Albertoni
Journal:  Epidemiol Infect       Date:  1990-06       Impact factor: 2.451

6.  Correlation of hepatocyte HBsAg expression with virus replication and liver pathology.

Authors:  H C Hsu; M Y Lai; I J Su; D S Chen; M H Chang; P M Yang; C Y Wu; H C Hsieh
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

7.  Pathology of chronic hepatitis B virus infection in children: with special reference to the intrahepatic expression of hepatitis B virus antigens.

Authors:  H C Hsu; Y H Lin; M H Chang; I J Su; D S Chen
Journal:  Hepatology       Date:  1988 Mar-Apr       Impact factor: 17.425

8.  Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen.

Authors:  F ter Borg; F J ten Kate; H T Cuypers; A Leentvaar-Kuijpers; J Oosting; P M Wertheim-van Dillen; P Honkoop; M C Rasch; R A de Man; J van Hattum; R A Chamuleau; H W Reesink; E A Jones
Journal:  Lancet       Date:  1998-06-27       Impact factor: 79.321

9.  Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen.

Authors:  H Okamoto; S Yotsumoto; Y Akahane; T Yamanaka; Y Miyazaki; Y Sugai; F Tsuda; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

10.  Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay.

Authors:  S Kaneko; R H Miller; S M Feinstone; M Unoura; K Kobayashi; N Hattori; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

View more
  12 in total

1.  Histological grading and staging of liver and its relation to viral loads in chronic anti-HBe positive hepatitis.

Authors:  Shahriar Shafaei; Shima Soleimani Amiri; Mahmoud Hajiahmadi; Mahmoud Sadeghi-Haddad-Zavareh; Masomeh Bayani
Journal:  Caspian J Intern Med       Date:  2013

2.  Evaluation of the need for treatment on 72 subjects with anti-HBe positive chronic hepatitis B.

Authors:  Shima Soleimani Amiri; Shariar Shafaee; Mohammad Reza Hasanjani Roushan; Masomeh Baiani; Mahmoud Hajiahmadi
Journal:  Caspian J Intern Med       Date:  2012

3.  A practical clinical approach to liver fibrosis.

Authors:  Rahul Kumar; Eng Kiong Teo; Choon How How; Teck Yee Wong; Tiing Leong Ang
Journal:  Singapore Med J       Date:  2018-12       Impact factor: 1.858

4.  Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.

Authors:  Philippe Bonnard; Roger Sombié; Francois-Xavier Lescure; Alain Bougouma; Jean Baptiste Guiard-Schmid; Thierry Poynard; Paul Calès; Chantal Housset; Patrice Callard; Catherine Le Pendeven; Joseph Drabo; Fabrice Carrat; Gilles Pialoux
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

Review 5.  Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.

Authors:  Pathik Parikh; John D Ryan; Emmanuel A Tsochatzis
Journal:  Ann Transl Med       Date:  2017-02

6.  A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B.

Authors:  Wai-Kay Seto; Chun-Fan Lee; Ching-Lung Lai; Philip P C Ip; Daniel Yee-Tak Fong; James Fung; Danny Ka-Ho Wong; Man-Fung Yuen
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

7.  A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.

Authors:  Wai-Kay Seto; Ching-Lung Lai; Philip P C Ip; James Fung; Danny Ka-Ho Wong; John Chi-Hang Yuen; Ivan Fan-Ngai Hung; Man-Fung Yuen
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

8.  Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase.

Authors:  Youwen Tan; Yun Ye; Xinbei Zhou; Li Chen; Danfeng Wen
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

9.  Parameters associated with significant liver histological changes in patients with chronic hepatitis B.

Authors:  Li Xiao; Jianchun Xian; Yang Li; Aiwen Geng; Xiuzhen Yang; Libin Han; Hongtao Xu
Journal:  ISRN Gastroenterol       Date:  2014-01-28

10.  Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALT.

Authors:  Baolin Liao; Zhanhui Wang; Siwei Lin; Ying Xu; Junqing Yi; Min Xu; Zuxiong Huang; Ying Zhou; Fuchun Zhang; Jinlin Hou
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.